Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoThe...Further, Moderna confirmed it's in discussions with the U.S. government to move forward with...
Sinovac denounces alleged US discredit campaign, warns of vaccine hesitancy risks
China Daily· 6 days agoChinese vaccine maker Sinovac Biotech said on Sunday that stigmatizing vaccines could contribute to vaccine hesitancy, undermine trust ...
Vaxart Provides Business Update
Morningstar· 5 days agoVaxart is developing the most advanced oral pill vaccine platform that provides a more convenient formulation compared to injectable vaccines, generates ...
Moderna Stock (NASDAQ:MRNA): Is There Life Beyond Disease Outbreaks?
TipRanks via Yahoo Finance· 5 days agoModerna (NASDAQ:MRNA) stock has surged 40.8% since the turn of the year. Some of this momentum can...
Gateway - Quartz
Quartz· 4 days agoModerna said Tuesday that its updated COVID-19 vaccine demonstrated a stronger immune response than its current jab in results from a phase-3 clinical & ...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 6 days agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc,...
New Human Cases of Avian Flu Anticipated
Medscape· 4 days agoWith avian influenza spreading quickly around the globe, the virus has more opportunities to mutate and cause problems for people. By some calculations,...
Drug names: How companies and regulators come up with hundreds of new names every year
Quartz· 3 days agoEverything you need to know about the art and science of drug naming in five minutes or less,...
Vaxart Stock Is Moving Higher After The Bell: What's Going On? - Vaxart (NASDAQ:VXRT)
Benzinga· 5 days agoVaxart Inc VXRT shares are trading higher in Monday’s after-hours session after the company provided...
The First Three Months
The Atlantic· 7 days agoA reporter calling me at home on a holiday about a possible disease outbreak was concerning, but not that unusual. The press sometimes had better, or at...